Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $247 | In Stock | |
5 mg | $619 | In Stock | |
10 mg | $993 | In Stock | |
25 mg | $1,470 | In Stock | |
50 mg | $1,980 | In Stock | |
100 mg | $2,680 | In Stock |
Description | Ravulizumab (ALXN1210) is a humanized monoclonal antibody targeting complement factor 5 that specifically binds to human complement protein C5 with high affinity to block complement activation. Ravulizumab can be used for the prevention and treatment of paroxysmal sleep hemoglobinuria, atypical hemolytic uremic syndrome and myasthenia gravis. |
In vitro | Binding to C5 with high affinity, Ravulizumab inhibits the formation of C5a and C5b, thereby preventing immune activation and hemolysis [1]. |
Alias | ALXN1210 |
Cas No. | 1803171-55-2 |
Storage | store at low temperature store at -80°C |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.